Related references
Note: Only part of the references are listed.Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Changes to Adjuvant Systemic Therapy in Breast Cancer: A Decade in Review
Christina A. Saurel et al.
CLINICAL BREAST CANCER (2010)
DNA polymerase θ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
Fanny Lemee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Breast cancer prognostication and prediction: are we making progress?
Alessandro Sgambato et al.
CANCER SCIENCE (2009)
Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression
Hannah Wingate et al.
CELL CYCLE (2009)
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome
G. Somlo et al.
ANNALS OF ONCOLOGY (2008)
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
Grace M. Callagy et al.
BMC CANCER (2008)
p27Kip1 and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
Peggy L. Porter et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
lImpact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients
Christine Desmedt et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
Donal J. Brennan et al.
CLINICAL CANCER RESEARCH (2006)
Cyclin E expression and prognosis in breast cancer patients: A meta-analysis of published studies
Lei Wang et al.
CANCER INVESTIGATION (2006)
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients
AM Sieuwerts et al.
CLINICAL CANCER RESEARCH (2006)
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
GM Callagy et al.
CLINICAL CANCER RESEARCH (2006)
Cyclin e overexpression reduces infiltrative growth in breast cancer - Yet another link between proliferation control and tumor invasion
Pontus Berglund et al.
CELL CYCLE (2006)
Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: A comparative study with immunostaining
P Potemski et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza et al.
ANNALS OF ONCOLOGY (2005)
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer
JB Arnes et al.
CLINICAL CANCER RESEARCH (2005)
Cyclin E expression in breast cancer:: predicting germline BRCA1 mutations, prognosis and response to treatment
PO Chappuis et al.
ANNALS OF ONCOLOGY (2005)
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer
T Lindahl et al.
CARCINOGENESIS (2004)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Deregulation of cyclin E in human cells interferes with prereplication complex assembly
S Ekholm-Reed et al.
JOURNAL OF CELL BIOLOGY (2004)
Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer
S Han et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
PN Span et al.
ONCOGENE (2003)
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer
P Rudolph et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Regulation of the mammalian cell cycle:: a model of the G1-to-S transition
ZL Qu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines
KH Moberg et al.
NATURE (2001)
Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer
HK Kim et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables
DG Altman
BMJ-BRITISH MEDICAL JOURNAL (2001)
Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas
IRK Bukholm et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications
R Donnellan et al.
HUMAN PATHOLOGY (2001)
Share Paper
